Erenumab for Idiosyncratic Facial Pain - Clinical Trial
What is the Purpose of this Study?
We are doing this study to test a drug, Erenumab, to see how well it works in lowering facial pain, pain medication use, and nose and sinus symptoms.
Who Can Participate in the Study?
-Adults 18-65 years old
-Have a sinus infection and/or facial pain or pressure.
What is Involved?
If you choose to join this study, you will:
-Be randomized (like the flip of a coin) to Group1 or Group 2
--Group 1 will get the study drug (Erenumab) once per month for 8 months
--Group 2 will get a placebo (harmess saltwater) once per month for 8 months
-Complete a pain diary daily
-Complete several questionnaires